Genemedicine (Biotechnology) Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Genemedicine (Biotechnology) General Information

Description

Developer of bio-pharmaceutical products. The company designs gene medicines to produce sustained levels of therapeutic proteins within the body. The company develops therapeutic products for both acute and chronic use and to be administered to patients through conventional means such as intramuscular or intravenous injection, or inhalation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8301 New Trails Drive
  • Spring, TX 77381
  • United States
+1 (281)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Megabios
Vertical(s)
Corporate Office
  • 8301 New Trails Drive
  • Spring, TX 77381
  • United States
+1 (281)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genemedicine (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 19-Mar-1999 Completed Generating Revenue
7. PIPE 10-Feb-1998 Completed Generating Revenue
6. PIPE 04-Feb-1997 Completed Generating Revenue
5. Grant 15-Oct-1996 Completed
4. PIPE 06-Feb-1996 Completed Generating Revenue
3. PIPE 14-Feb-1995 Completed Generating Revenue
2. IPO 01-Jul-1994 $13.5M $22M Completed Generating Revenue
1. Early Stage VC 17-May-1993 $8.5M $8.5M Completed Product Development
To view Genemedicine (Biotechnology)’s complete valuation and funding history, request access »

Genemedicine (Biotechnology) Patents

Genemedicine (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2000011137-A1 Acid labile cationic amphiphiles Inactive 24-Aug-1998
WO-1999047678-A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same Inactive 19-Mar-1998
WO-1999031262-A2 Needle-free injection of formulated nucleic acid molecules Inactive 16-Dec-1997
WO-1999024596-A1 Expression plasmids for multiepitope nucleic acid-based vaccines Inactive 12-Nov-1997
WO-1999012945-A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use Inactive 08-Sep-1997 C12N15/87
To view Genemedicine (Biotechnology)’s complete patent history, request access »

Genemedicine (Biotechnology) Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
CHL Medical Partners Venture Capital Minority
New Enterprise Associates Venture Capital Minority
Roche Boehringer Mannheim Diagnostics Corporation Minority
The Bioscience Investment Trust Limited Partner Minority
You’re viewing 5 of 6 investors. Get the full list »

Genemedicine (Biotechnology) FAQs

  • When was Genemedicine (Biotechnology) founded?

    Genemedicine (Biotechnology) was founded in 1992.

  • Where is Genemedicine (Biotechnology) headquartered?

    Genemedicine (Biotechnology) is headquartered in Spring, TX.

  • What industry is Genemedicine (Biotechnology) in?

    Genemedicine (Biotechnology)’s primary industry is Biotechnology.

  • Is Genemedicine (Biotechnology) a private or public company?

    Genemedicine (Biotechnology) is a Private company.

  • What is Genemedicine (Biotechnology)’s current revenue?

    The current revenue for Genemedicine (Biotechnology) is .

  • How much funding has Genemedicine (Biotechnology) raised over time?

    Genemedicine (Biotechnology) has raised $35.2M.

  • Who are Genemedicine (Biotechnology)’s investors?

    Abingworth, CHL Medical Partners, New Enterprise Associates, Roche Boehringer Mannheim Diagnostics, and The Bioscience Investment Trust are 5 of 6 investors who have invested in Genemedicine (Biotechnology).

  • When was Genemedicine (Biotechnology) acquired?

    Genemedicine (Biotechnology) was acquired on 19-Mar-1999.

  • Who acquired Genemedicine (Biotechnology)?

    Genemedicine (Biotechnology) was acquired by Megabios.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process